Literature DB >> 12739773

Topical delivery of 5-fluorouracil and 6-mercaptopurine by their alkylcarbonyloxymethyl prodrugs from water: vehicle effects on design of prodrugs.

Kenneth B Sloan1, Scott Wasdo, Udo Ezike-Mkparu, Thomas Murray, Donna Nickels, Surjit Singh, Thea Shanks, John Tovar, Karen Ulmer, Robert Waranis.   

Abstract

PURPOSE: To determine whether the fluxes through hairless mouse skin for three homologous series of prodrugs of 5-fluorouracil (5-FU, 1) and 6-mercaptopurine (6-MP, 2) from saturated aqueous suspensions show dependencies on aqueous (SAQ) and isopropyl myristate (SIPM) solubilities similar to those shown by the identical compounds delivered from IPM.
METHODS: Flux through hairless mouse skin from water (JMAQ) and solubility data were measured for a homologous series of six 3-alkylcarbonyloxymethyl (ACOM) prodrugs of 5-FU (3-ACOM-5-FU), and five 6-ACOM-6-MP prodrugs, then combined with literature data for five bis-6,9-ACOM-6-MP prodrugs to give a data base. Multiple linear regression using SPSS 7.5 was performed on log SIPM, log SAQ, molecular weight and log JMAQ data to determine the best fit coefficients to the transformed Potts-Guy equation: log JMAQ = x + y log SIPM + (1 - y) log SAQ + z MW. Permeability coefficients (PMAQ) were calculated from JMAQ/SAQ.
RESULTS: The best fit coefficients for the flux from AQ(JMAQ) were x = -1.497, y = 0.660 and z = -0.00469 (r2 = 0.765) with an average error of prediction equal to 0.193 log units. The best fit coefficients for the flux from IPM (JMIPM) were x = -0.557, y = 0.536 and z = -0.00261 (r2 = 0.941) with an average error of prediction equal to 0.109 log units. For all three series, log PMAQ increased whereas log PMIPM decreased with increasing alkyl chain lengths in the promoiety and with decreasing solubility parameter values.
CONCLUSIONS: The transformed Potts-Guy equation can be used to predict JMAQ but with less certainty than JMIPM. SIPM and SAQ have consistently been shown to have a positive influence on JMIPM, and now on JMAQ, with a balance between the two solubilities being obviously important. The previous observation that log PMAQ increased with lipophilicity is an artifact of normalizing JMAQ by SAQ.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12739773     DOI: 10.1023/a:1023207118209

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  12 in total

1.  Skin penetration of nonsteroidal antiinflammatory drugs out of a lipophilic vehicle: influence of the viable epidermis.

Authors:  B P Wenkers; B C Lippold
Journal:  J Pharm Sci       Date:  1999-12       Impact factor: 3.534

2.  Application of the transformed Potts-Guy equation to in vivo human skin data.

Authors:  W J Roberts; K B Sloan
Journal:  J Pharm Sci       Date:  2001-09       Impact factor: 3.534

3.  Correlation of aqueous and lipid solubilities with flux for prodrugs of 5-fluorouracil, theophylline, and 6-mercaptopurine: A Potts-Guy approach.

Authors:  W J Roberts; K B Sloan
Journal:  J Pharm Sci       Date:  1999-05       Impact factor: 3.534

4.  Predicting skin permeability.

Authors:  R O Potts; R H Guy
Journal:  Pharm Res       Date:  1992-05       Impact factor: 4.200

Review 5.  The selection and design of topical and transdermal agents: a review.

Authors:  J Hadgraft; W J Pugh
Journal:  J Investig Dermatol Symp Proc       Date:  1998-08

6.  Extended Hildebrand solubility approach: sulfonamides in binary and ternary solvents.

Authors:  A Martin; P L Wu; T Velasquez
Journal:  J Pharm Sci       Date:  1985-03       Impact factor: 3.534

7.  Topical delivery of 5-fluorouracil (5-Fu) by 3-alkylcarbonyl-5-Fu prodrugs.

Authors:  H D Beall; K B Sloan
Journal:  Int J Pharm       Date:  2001-04-17       Impact factor: 5.875

8.  Prediction of transdermal flux of prodrugs of 5-fluorouracil, theophylline, and 6-mercaptopurine with a series/parallel model.

Authors:  W J Roberts; K B Sloan
Journal:  J Pharm Sci       Date:  2000-11       Impact factor: 3.534

9.  Topical delivery of 5-fluorouracil (5-FU) by 3-alkylcarbonyloxymethyl-5-FU prodrugs.

Authors:  William J Roberts; Kenneth B Sloan
Journal:  J Pharm Sci       Date:  2003-05       Impact factor: 3.534

10.  Effects of vehicles and prodrug properties and their interactions on the delivery of 6-mercaptopurine through skin: S6-acyloxymethyl-6-mercaptopurine prodrugs.

Authors:  R P Waranis; K B Sloan
Journal:  J Pharm Sci       Date:  1988-03       Impact factor: 3.534

View more
  4 in total

1.  Prodrugs of theophylline incorporating ethyleneoxy groups in the promoiety: synthesis, characterization, and transdermal delivery.

Authors:  Susruta Majumdar; Maren Mueller-Spaeth; Kenneth B Sloan
Journal:  AAPS PharmSciTech       Date:  2012-05-31       Impact factor: 3.246

2.  Topical delivery of a model phenolic drug: alkyloxycarbonyl prodrugs of acetaminophen.

Authors:  Scott C Wasdo; Kenneth B Sloan
Journal:  Pharm Res       Date:  2004-06       Impact factor: 4.200

Review 3.  Design for optimized topical delivery: Prodrugs and a paradigm change.

Authors:  Kenneth B Sloan; Scott C Wasdo; Jarkko Rautio
Journal:  Pharm Res       Date:  2006-11-16       Impact factor: 4.580

4.  Soft alkyl ether prodrugs of a model phenolic drug: the effect of incorporation of ethyleneoxy groups on transdermal delivery.

Authors:  Joshua Denver Thomas; Susruta Majumdar; Kenneth Berry Sloan
Journal:  Molecules       Date:  2009-10-22       Impact factor: 4.411

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.